Tessier-Lavigne Marc (CIK 0001437435)

Latest company ownership

Shares held
78,848
Last filed at
Dec 30, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q2 2025Q4
Shares held
1,929
Last filed at
Jan 5, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Nov 23, 2022 Nov 28, 2022 Denali Therapeutics Inc. Director Sell 45.0 -20,000 -0.94% $609.6K
Nov 1, 2022 Nov 3, 2022 Denali Therapeutics Inc. Director Sell 45.0 -20,000 -0.93% $605.5K
Sep 29, 2022 Oct 3, 2022 REGENERON PHARMACEUTICALS, INC. Director Sell 13.8 -10,838 -18.96% $7.6M
Sep 28, 2022 Sep 30, 2022 Denali Therapeutics Inc. Director Sell 45.0 -20,000 -0.92% $616.3K
Aug 23, 2022 Aug 25, 2022 Denali Therapeutics Inc. Director Sell 45.0 -20,000 -0.91% $632.3K
Jul 25, 2022 Jul 27, 2022 Denali Therapeutics Inc. Director Sell 30.0 -20,000 -0.91% $712.1K
Mar 23, 2022 Jun 28, 2022 Denali Therapeutics Inc. Director Sell 30.0 -20,000 -0.88% $676.6K
Jun 23, 2022 Jun 27, 2022 Denali Therapeutics Inc. Director Sell 17.5 -60,000 -2.65% $1.8M
Mar 23, 2022 Mar 25, 2022 Denali Therapeutics Inc. Director Sell 30.0 -20,000 -0.88% $676.6K
Mar 21, 2022 Mar 23, 2022 REGENERON PHARMACEUTICALS, INC. Director Sell 3.8 -7,439 -76.63% $5.1M
Mar 16, 2022 Mar 18, 2022 REGENERON PHARMACEUTICALS, INC. Director Sell 3.8 -12,191 -72.87% $8.3M
Oct 4, 2021 Dec 30, 2021 Denali Therapeutics Inc. Director Sell 17.5 -63,131 -2.48% $2.8M
Dec 9, 2021 Dec 10, 2021 REGENERON PHARMACEUTICALS, INC. Director Sell 5.0 -3,784 -64.55% $2.5M
Sep 13, 2021 Sep 15, 2021 REGENERON PHARMACEUTICALS, INC. Director Sell 3.8 -12,750 -85.99% $8.2M
Jun 7, 2021 Jun 8, 2021 Denali Therapeutics Inc. Director Sell 31.3 -94,378 -3.58% $6.6M
May 21, 2021 May 24, 2021 Denali Therapeutics Inc. Director Sell 40.0 -46,763 -1.81% $2.8M
May 3, 2021 May 5, 2021 Denali Therapeutics Inc. Director Sell 50.0 -3,237 -0.12% $194.6K
Apr 1, 2021 Apr 5, 2021 Denali Therapeutics Inc. Director Sell 40.0 -50,000 -1.89% $2.8M
Mar 1, 2021 Mar 3, 2021 Denali Therapeutics Inc. Director Sell 31.3 -100,000 -3.65% $6.6M
Jun 16, 2020 Jun 18, 2020 Denali Therapeutics Inc. Director Sell 15.0 -400,000 -12.74% $10.4M
May 6, 2020 May 8, 2020 REGENERON PHARMACEUTICALS, INC. Director Sell 16.3 -15,000 -89.13% $8.5M
Feb 13, 2020 Feb 14, 2020 REGENERON PHARMACEUTICALS, INC. Director Sell 16.3 -14,279 -37.49% $5.7M